Trenton Gray
Nurse Practitioner · South Salt Lake, UTNPI 1639692510
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,698 of the $40,313 with a category attached, or 71.2%. Amgen accounts for 86.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $26,403 and has fallen 75.3% since, to $6,518 in 2025. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $160.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$35K
- ANI Pharmaceuticals, Inc.$2K
- Novo Nordisk$908
- AstraZeneca$576
- Boehringer Ingelheim$262
- Otsuka America Pharmaceutical, Inc.$260
- plus $2K from 17 others
What the payments were for
- Consulting fees$9082%
- Speaking & faculty fees$28,69871%
- Travel & lodging$5,06213%
- Food & beverage$5,64314%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 109 | $34,675 |
| ANI Pharmaceuticals, Inc. | 12 | $2,085 |
| Novo Nordisk | 2 | $908 |
| AstraZeneca(2 entities) | 31 | $576 |
| Boehringer Ingelheim | 14 | $262 |
| Otsuka America Pharmaceutical, Inc. | 15 | $260 |
| Travere Therapeutics, Inc. | 9 | $214 |
| Vifor Pharma, Inc. | 9 | $199 |
| Lilly USA, LLC | 5 | $164 |
| GSK | 8 | $160 |
| Fresenius USA Marketing, Inc. | 8 | $131 |
| Bayer | 7 | $131 |
| Alnylam Pharmaceuticals Inc. | 4 | $114 |
| Ardelyx, Inc. | 5 | $98 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Calliditas Therapeutics US Inc. | 2 | $45 |
| Veloxis Pharmaceuticals, Inc. | 1 | $44 |
| Chiesi USA, Inc. | 1 | $36 |
| Novartis | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$30,511
- PURIFIED CORTROPHIN GEL$1,788
- Rivfloza$908
How this compares
$40,313 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 11 | $2,613 |
| Losartan Potassium | 23 | $641 |
| Torsemide | 14 | $419 |
| Carvedilol | 21 | $364 |
| Potassium Chloride | 12 | $328 |
| Chlorthalidone | 15 | $300 |
| Allopurinol | 33 | $284 |
| Lisinopril | 28 | $283 |
| Amlodipine Besylate | 36 | $232 |
| Furosemide | 22 | $201 |
| Atorvastatin Calcium | 11 | $117 |
| Spironolactone | 12 | $87 |
| Trazodone Hcl | 11 | $83 |
| Hydralazine Hcl | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in South Salt Lake
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Lynn LarsenOgden$16K
- Phillip BowmanSalt Lake City$13K
- Marinda PaskettOgden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.